Zoetis (ZTS) Short-Term Debt issuances (2013 - 2024)
Zoetis (ZTS) posted quarterly Short-Term Debt issuances of -$24.0 million for Q2 2024, down 2300.0% year-over-year from $1.1 million in Q3 2023, and down 214.29% quarter-over-quarter from $21.0 million in Q1 2024.
Zoetis (ZTS) Short-Term Debt issuances (2013 - 2024) Analysis & Trends
Zoetis (ZTS) has reported Short-Term Debt issuances for 12 consecutive years, with -$24.0 million the latest figure, recorded in Q2 2024.
- In Q2 2024, Short-Term Debt issuances fell 2300.0% year-over-year to -$24.0 million; the TTM figure through Mar 2025 stood at -$24.0 million (down 214.29% YoY), while the FY2024 annual figure was -$3.0 million, down 400.0% from the prior year.
- Short-Term Debt issuances eased to -$24.0 million in Q2 2024 per ZTS's latest filing, from $21.0 million in the prior quarter.
- Across five years, Short-Term Debt issuances topped out at $21.0 million in Q1 2024 and bottomed at -$24.0 million in Q2 2024.
- Historically, Short-Term Debt issuances has averaged $0.0 across 5 years, with a median of $1.0 million in 2020.
- On a YoY basis, Short-Term Debt issuances climbed as much as 2000.0% in 2024 and fell as far as 2300.0% in 2024.
- Zoetis' Short-Term Debt issuances stood at $3.0 million in 2020, then slumped by 233.33% to -$4.0 million in 2021, then jumped by 75.0% to -$1.0 million in 2022, then surged by 200.0% to $1.0 million in 2023, then sank by 2500.0% to -$24.0 million in 2024.
- Business Quant data shows ZTS's Short-Term Debt issuances at -$24.0 million in Q2 2024, $21.0 million in Q1 2024, and $1.0 million in Q4 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Short-Term Debt issuances (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | - |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 50.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Alkermes | 8.07 Bn | 7.41 Bn | 397.90 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | -24.00 Mn |
| Jun 30, 2024 | -24.00 Mn |
| Mar 31, 2024 | 21.00 Mn |
| Mar 31, 2024 | 21.00 Mn |
| Dec 31, 2023 | 1.00 Mn |
| Dec 31, 2023 | 1.00 Mn |
| Jun 30, 2023 | -1.00 Mn |
| Jun 30, 2023 | -1.00 Mn |
| Mar 31, 2023 | 1.00 Mn |
| Mar 31, 2023 | 1.00 Mn |
| Dec 31, 2022 | -1.00 Mn |
| Dec 31, 2022 | -1.00 Mn |
| Sep 30, 2022 | 1.00 Mn |
| Sep 30, 2022 | 1.00 Mn |
| Jun 30, 2022 | 2.00 Mn |
| Jun 30, 2022 | 2.00 Mn |
| Sep 30, 2021 | -4.00 Mn |
| Sep 30, 2021 | -4.00 Mn |
| Dec 31, 2020 | 3.00 Mn |
| Dec 31, 2020 | 3.00 Mn |